Cerebrospinal Fluid Findings among Patients with Anaplasmosis and Central Nervous Involvement, Minnesota and Wisconsin, USA

Read full text
Authors: Igor Dumic, Charles W. Nordstrom, Marie Schulz, Sagar B. Dugani, John Fox, Ronin Joshua Cosiquien, Tatjana Gavrancic, Margaret Paulson, Cristian Madrid, Wendelyn Bosch
Cited by: 1
References: 29

Abstract

Anaplasmosis, an emerging tickborne zoonosis, infrequently involves the central nervous system, and cerebrospinal fluid (CSF) profiles of anaplasmosis remain poorly characterized. We conducted a multisite retrospective study of patients hospitalized with anaplasmosis during November 1, 2014-November 29, 2024, in Minnesota and Wisconsin, USA, a hyperendemic region. Included patients had anaplasmosis confirmed by PCR on blood samples, exhibited neurologic symptoms, and had lumbar puncture procedures. Ten hospitalized patients met inclusion criteria, 6 with meningitis, 3 with meningoencephalitis, and 1 with encephalitis. CSF findings were within reference ranges for 5 patients; 4 patients demonstrated mild lymphocytic pleocytosis, but glucose and protein levels were within reference ranges. One patient underwent a traumatic lumbar puncture resulting in neutrophilic pleocytosis. CSF abnormalities did not correlate with neurologic severity, suggesting a cytokine-mediated process rather than direct central nervous system infection. All patients rapidly improved with doxycycline, highlighting the need for early recognition and empiric therapy for anaplasmosis.

Fields of Study & Subjects

Multiple Sclerosis Research Studies Bacterial Infections and Vaccines Vector-borne infectious diseases

Publication details

Journal / source
Emerging infectious diseases
Publisher
Centers for Disease Control and Prevention (CDC)
Volume
32
Issue
6
Pages
844–850
Publication date
15 May 2026
Language
EN